TriSalus Life Sciences, Inc. (TLSI) Gross margin 2022–2025
TriSalus Life Sciences, Inc. (TLSI) gross margin by fiscal year — reported gross profit divided by reported revenue.
84.6%FY2025 · since FY2022: 81.8% → 84.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 84.6% | -1.5 pp |
| FY2024 | 86.1% | +0.1 pp |
| FY2023 | 85.9% | +4.1 pp |
| FY2022 | 81.8% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More TLSI financial trends
TLSI RevenueTLSI Net incomeTLSI Net marginTLSI Gross profitTLSI Operating incomeTLSI Operating marginTLSI Operating cash flowTLSI Free cash flowTLSI Capital expendituresTLSI Return on equityTLSI Stock buybacksTLSI Dividends paidTLSI Total assetsTLSI Total liabilitiesTLSI Shareholders’ equityTLSI overview →